| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1842 |
| Trial ID | NCT03383952 |
| Disease | B-Cell Leukemia | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia |
| Year | 2017 |
| Country | China |
| Company sponsor | Immune Cell, Inc. |
| Other ID(s) | CD19 Targeted CAR-T |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||